|
10 Companies |
|
5 Products |
|
5 Products |
|
0 Mechanisms of Action |
|
3 Trials |
|
46 News |
|
- otesaconazole (VT-1161) / Mycovia Pharma
Phase classification: A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Moderate - Severe Interdigital Tinea Pedis (clinicaltrials.gov) - Jul 6, 2018
P2a, N=50, Completed, Sponsor: Viamet
Phase classification: P2 --> P2a
- || NN1213 / Novo Nordisk
Enrollment change, Trial completion date, Trial primary completion date: Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin (clinicaltrials.gov) - Jun 28, 2018
P1, N=1519, Completed, Sponsor: Taro Pharmaceuticals USA
Phase classification: P2 --> P2a N=690 --> 1519 | Trial completion date: Jan 2015 --> May 2018 | Trial primary completion date: Dec 2014 --> May 2018
- |||| SB208 / Novan
Trial completion: SB208 for the Treatment of Tinea Pedis (clinicaltrials.gov) - Dec 18, 2017
P2, N=222, Completed, Sponsor: Novan, Inc.
N=690 --> 1519 | Trial completion date: Jan 2015 --> May 2018 | Trial primary completion date: Dec 2014 --> May 2018 Active, not recruiting --> Completed
- ketoconazole / Generic mfg.
Enrollment change, Trial withdrawal, Head-to-Head: Non-inferiority Phase III Trial Comparing Dapaconazole Cream 2% With Ketoconazole Cream 2% in Patients With Tinea Pedis (clinicaltrials.gov) - Feb 1, 2017
P3, N=0, Withdrawn, Sponsor: Biolab Sanus Farmaceutica
Active, not recruiting --> Completed N=140 --> 0 | Not yet recruiting --> Withdrawn
- ||| SB208 / Novan
Clinical: SB208 for the Treatment of Tinea Pedis (clinicaltrials.gov) - Jan 4, 2017
P2, N=222, Active, not recruiting, Sponsor: Novan, Inc.
N=140 --> 0 | Not yet recruiting --> Withdrawn Recruiting --> Active, not recruiting | N=170 --> 222
- ||||| SB208 / Novan
New P2 trial: SB208 for the Treatment of Tinea Pedis (clinicaltrials.gov) - Aug 9, 2016
P2, N=170, Recruiting, Sponsor: Novan, Inc.
- ||||| ketoconazole / Generic mfg.
New P2 trial, Head-to-Head: Clinical Trial Comparing BL123 Versus Ketoconazole in Patients With Tinea Pedis (clinicaltrials.gov) - Jul 7, 2016
P2, N=60, Completed, Sponsor: Gilberto De Nucci
- ||||| ketoconazole / Generic mfg.
Trial initiation date, Trial primary completion date, Head-to-Head: Non-inferiority Phase III Trial Comparing Dapaconazole Cream 2% With Ketoconazole Cream 2% in Patients With Tinea Pedis (clinicaltrials.gov) - Feb 8, 2016
P3, N=140, Not yet recruiting, Sponsor: Biolab Sanus Farmaceutica
Recruiting --> Active, not recruiting | N=170 --> 222 Initiation date: Jan 2016 --> Jun 2016 | Trial primary completion date: Aug 2016 --> Dec 2016
- || New P3 trial: BE Study of Naftifine HCL (clinicaltrials.gov) - Dec 17, 2015
P3, N=693, Completed, Sponsor: Semler Research Center Pvt. Ltd.
- |||||||||| ketoconazole / Generic mfg.
New P3 trial, Head-to-Head: Non-inferiority Phase III Trial Comparing Dapaconazole Cream 2% With Ketoconazole Cream 2% in Patients With Tinea Pedis (clinicaltrials.gov) - Nov 17, 2015
P3, N=140, Not yet recruiting, Sponsor: Biolab Sanus Farmaceutica
- Psoralen / EMD Serono
Phase classification, Trial termination: Study to Compare Different Light Therapies (Narrowband Ultraviolet B vs PUVA) for Hand and Foot Skin Diseases. (clinicaltrials.gov) - May 20, 2015
P0, N=3, Terminated, Sponsor: Mayo Clinic
Phase classification: P4 --> P0 | Withdrawn --> Terminated; Unfortunately we had unforeseen difficulty recruiting to this study. Therefore we have decided to halt the study and not publish the results.
- ||| Trial completion: Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin (clinicaltrials.gov) - Feb 8, 2015
P1, N=690, Completed, Sponsor: Taro Pharmaceuticals USA
Therefore we have decided to halt the study and not publish the results. Active, not recruiting --> Completed
- ||| New P1 trial: Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin (clinicaltrials.gov) - Jan 9, 2015
P1, N=690, Active, not recruiting, Sponsor: Taro Pharmaceuticals USA
- | otesaconazole (VT-1161) / Mycovia Pharma
Trial completion: A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Moderate - Severe Interdigital Tinea Pedis (clinicaltrials.gov) - Dec 25, 2014
P2, N=50, Completed, Sponsor: Viamet Pharmaceuticals, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- New P2 trial: KR: Evaluation of Preclinical Toxicity andTherapeutic Efficacy of Kandhaga Rasayanam in Padarthamarai (clinicaltrials.gov) - Sep 12, 2014
P2, N=50, Completed, Sponsor: National institute of Siddha
- ||| New P1 trial: Evaluate the Safety and Efficacy of Naftifine Hydrochloride Cream 2% and Naftin (clinicaltrials.gov) - May 5, 2014
P1, N=890, Completed, Sponsor: Taro Pharmaceuticals USA
- | otesaconazole (VT-1161) / Mycovia Pharma
Enrollment closed: A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Moderate - Severe Interdigital Tinea Pedis (clinicaltrials.gov) - Mar 9, 2014
P2, N=48, Active, not recruiting, Sponsor: Viamet Pharmaceuticals, Inc.
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- ||||||| Trial completion: Evaluate the Clinical Equivalence of Two Naftifine HCl 1% Creams in Patients With Interdigital Tinea Pedis (clinicaltrials.gov) - Dec 18, 2013
P3, N=1053, Completed, Sponsor: Taro Pharmaceuticals USA
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- ||| clotrimazole topical / Generic mfg.
Trial completion: Evaluate the Safety & Bioequivalence of a Generic Butenafine Cream & Lotrimin Ultra (clinicaltrials.gov) - Dec 18, 2013
P1, N=707, Completed, Sponsor: Taro Pharmaceuticals USA
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||| Trial completion: A Therapeutic Equivalence Study of Two Oxiconazole Nitrate Topical Cream Treatments for Patients With Tinea Pedis (clinicaltrials.gov) - Dec 18, 2013
P1, N=661, Completed, Sponsor: Taro Pharmaceuticals USA
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||| Naftin (naftifine hydrochloride) / Merz Pharma
Trial completion: Pharmacokinetic Study of Pediatric Subjects With Tinea Cruris and Tinea Pedis (clinicaltrials.gov) - Sep 12, 2013
P4, N=65, Completed, Sponsor: Merz Pharmaceuticals, LLC
Active, not recruiting --> Completed Recruiting --> Completed
- | otesaconazole (VT-1161) / Mycovia Pharma
New P2 trial: A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Moderate - Severe Interdigital Tinea Pedis (clinicaltrials.gov) - Jul 1, 2013
P2, N=48, Active, not recruiting, Sponsor: Viamet Pharmaceuticals, Inc.
- ||||||| Kerydin (tavaborole) / Pfizer
Trial completion: Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the Toenail (clinicaltrials.gov) - Jun 10, 2013
P3, N=604, Completed, Sponsor: Anacor Pharmaceuticals, Inc.
Recruiting --> Completed Active, not recruiting --> Completed
- ||||||| Kerydin (tavaborole) / Pfizer
Trial completion: Efficacy and Safety Evaluation of AN2690 Topical Solution to Treat Onychomycosis of the Toenail (clinicaltrials.gov) - Jun 10, 2013
P3, N=594, Completed, Sponsor: Anacor Pharmaceuticals, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | ketoconazole / Generic mfg.
Enrollment change: An Efficacy Study of a New Formulation of Ketoconazole 2% Cream in Patients With Tinea Pedis, Commonly Known as Athlete's Foot (clinicaltrials.gov) - Apr 30, 2013
P3, N=583, Terminated, Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Active, not recruiting --> Completed N=466 --> 583
- Enrollment change: Hygienic Socks With Antifungal Agent-loaded Microcapsules for Patients With Tinea Pedis (clinicaltrials.gov) - Mar 30, 2013
P3, N=42, Completed, Sponsor: Prof. Yuen Chun-Wah
N=466 --> 583 N=100 --> 42
- Trial completion: Hygienic Socks With Antifungal Agent-loaded Microcapsules for Patients With Tinea Pedis (clinicaltrials.gov) - Mar 30, 2013
P3, N=42, Completed, Sponsor: Prof. Yuen Chun-Wah
N=100 --> 42 Recruiting --> Completed
- ||||||| Trial completion: Topical Antifungal Treatment for Tinea Pedis (clinicaltrials.gov) - Jan 21, 2013
P3, N=322, Completed, Sponsor: Medicis Global Service Corporation
Recruiting --> Completed Active, not recruiting --> Completed
- ||||||| Trial completion: Topical Antifungal Treatment for Tinea Pedis (clinicaltrials.gov) - Jan 21, 2013
P3, N=321, Completed, Sponsor: Medicis Global Service Corporation
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||||| Trial completion: Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis (clinicaltrials.gov) - Jan 21, 2013
P3, N=604, Completed, Sponsor: Tinea Pharmaceuticals
Active, not recruiting --> Completed Recruiting --> Completed
- ||||| Naftin (naftifine hydrochloride) / Merz Pharma
New P4 trial: Pharmacokinetic Study of Pediatric Subjects With Tinea Cruris and Tinea Pedis (clinicaltrials.gov) - Oct 21, 2012
P4, N=65, Completed, Sponsor: Merz Pharmaceuticals, LLC
- New P2 trial: Comparative PK Study of Econazole Nitrate Foam and Econazole Nitrate Cream in Subjects With Interdigital Tinea Pedis Aged 12 Years to Less Than 18 Years (clinicaltrials.gov) - Sep 27, 2012
P2, N=42, Completed, Sponsor: Quinnova Pharmaceuticals, Inc.
- ||||||| Trial completion: Safety and Efficacy of Econazole Nitrate Foam 1% and Foam Vehicle in Subjects With Tinea Pedis (clinicaltrials.gov) - Sep 26, 2012
P3, N=336, Completed, Sponsor: AmDerma
Recruiting --> Completed Recruiting --> Completed
- ||||||| Trial completion: Safety and Efficacy of Econazole Nitrate Foam 1% in Subjects With Tinea Pedis (clinicaltrials.gov) - Sep 23, 2012
P3, N=264, Completed, Sponsor: AmDerma
Recruiting --> Completed Recruiting --> Completed
- |||||||||| New P3 trial: Evaluate the Clinical Equivalence of Two Naftifine HCl 1% Creams in Patients With Interdigital Tinea Pedis (clinicaltrials.gov) - Apr 17, 2012
P3, N=1053, Completed, Sponsor: Taro Pharmaceuticals USA
- ||| clotrimazole topical / Generic mfg.
New P1 trial: Evaluate the Safety & Bioequivalence of a Generic Butenafine Cream & Lotrimin Ultra (clinicaltrials.gov) - Apr 17, 2012
P1, N=707, Completed, Sponsor: Taro Pharmaceuticals USA
- ||||||| Trial completion: Efficacy and Safety of Terbinafine Film Forming Solution in Patients With Tinea Pedis (clinicaltrials.gov) - Mar 13, 2012
P3, N=290, Completed, Sponsor: Novartis
Recruiting --> Completed Active, not recruiting --> Completed
- New P3 trial: Hygienic Socks With Antifungal Agent-loaded Microcapsules for Patients With Tinea Pedis (clinicaltrials.gov) - Jan 31, 2012
P3, N=42, Completed, Sponsor: Prof. Yuen Chun-Wah
- ||| New P1 trial: A Therapeutic Equivalence Study of Two Oxiconazole Nitrate Topical Cream Treatments for Patients With Tinea Pedis (clinicaltrials.gov) - Jan 25, 2012
P1, N=661, Completed, Sponsor: Taro Pharmaceuticals USA
- ||||||| Naftin (naftifine hydrochloride) / Merz Pharma
Trial completion: Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis (clinicaltrials.gov) - Jan 22, 2012
P3, N=860, Completed, Sponsor: Merz Pharmaceuticals, LLC
Active, not recruiting --> Completed Recruiting --> Completed
- ||||||| Naftin (naftifine hydrochloride) / Merz Pharma
Trial completion: Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis (clinicaltrials.gov) - Jan 22, 2012
P3, N=855, Completed, Sponsor: Merz Pharmaceuticals, LLC
Recruiting --> Completed Recruiting --> Completed
- |||||||||| New P3 trial: Efficacy and Safety of Terbinafine Film Forming Solution in Patients With Tinea Pedis (clinicaltrials.gov) - Sep 11, 2011
P3, N=290, Completed, Sponsor: Novartis